Cargando…

Survey and online discussion groups to develop a patient-rated outcome measure on acceptability of treatment response in vitiligo

BACKGROUND: Vitiligo is a chronic depigmenting skin disorder which affects around 0.5-1% of the world’s population. The outcome measures used most commonly in trials to judge treatment success focus on repigmentation. Patient-reported outcome measures of treatment success are rarely used, although r...

Descripción completa

Detalles Bibliográficos
Autores principales: Tour, Selina K, Thomas, Kim S, Walker, Dawn-Marie, Leighton, Paul, Yong, Adrian SW, Batchelor, Jonathan M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075774/
https://www.ncbi.nlm.nih.gov/pubmed/24929563
http://dx.doi.org/10.1186/1471-5945-14-10
_version_ 1782323390333321216
author Tour, Selina K
Thomas, Kim S
Walker, Dawn-Marie
Leighton, Paul
Yong, Adrian SW
Batchelor, Jonathan M
author_facet Tour, Selina K
Thomas, Kim S
Walker, Dawn-Marie
Leighton, Paul
Yong, Adrian SW
Batchelor, Jonathan M
author_sort Tour, Selina K
collection PubMed
description BACKGROUND: Vitiligo is a chronic depigmenting skin disorder which affects around 0.5-1% of the world’s population. The outcome measures used most commonly in trials to judge treatment success focus on repigmentation. Patient-reported outcome measures of treatment success are rarely used, although recommendations have been made for their inclusion in vitiligo trials. This study aimed to evaluate the face validity of a new patient-reported outcome measure of treatment response, for use in future trials and clinical practice. METHOD: An online survey to gather initial views on what constitutes treatment success for people with vitiligo or their parents/carers, followed by online discussion groups with patients to reach consensus on what constitutes treatment success for individuals with vitiligo, and how this can be assessed in the context of trials. Participants were recruited from an existing database of vitiligo patients and through posts on the social network sites Facebook and Twitter. RESULTS: A total of 202 survey responses were received, of which 37 were excluded and 165 analysed. Three main themes emerged as important in assessing treatment response: a) the match between vitiligo and normal skin (how well it blends in); b) how noticeable the vitiligo is and c) a reduction in the size of the white patches. The majority of respondents said they would consider 80% or more repigmentation to be a worthwhile treatment response after 9 months of treatment. Three online discussion groups involving 12 participants led to consensus that treatment success is best measured by asking patients how noticeable their vitiligo is after treatment. This was judged to be best answered using a 5-point Likert scale, on which a score of 4 or 5 represents treatment success. CONCLUSIONS: This study represents the first step in developing a patient reported measure of treatment success in vitiligo trials. Further work is now needed to assess its construct validity and responsiveness to change.
format Online
Article
Text
id pubmed-4075774
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40757742014-07-01 Survey and online discussion groups to develop a patient-rated outcome measure on acceptability of treatment response in vitiligo Tour, Selina K Thomas, Kim S Walker, Dawn-Marie Leighton, Paul Yong, Adrian SW Batchelor, Jonathan M BMC Dermatol Research Article BACKGROUND: Vitiligo is a chronic depigmenting skin disorder which affects around 0.5-1% of the world’s population. The outcome measures used most commonly in trials to judge treatment success focus on repigmentation. Patient-reported outcome measures of treatment success are rarely used, although recommendations have been made for their inclusion in vitiligo trials. This study aimed to evaluate the face validity of a new patient-reported outcome measure of treatment response, for use in future trials and clinical practice. METHOD: An online survey to gather initial views on what constitutes treatment success for people with vitiligo or their parents/carers, followed by online discussion groups with patients to reach consensus on what constitutes treatment success for individuals with vitiligo, and how this can be assessed in the context of trials. Participants were recruited from an existing database of vitiligo patients and through posts on the social network sites Facebook and Twitter. RESULTS: A total of 202 survey responses were received, of which 37 were excluded and 165 analysed. Three main themes emerged as important in assessing treatment response: a) the match between vitiligo and normal skin (how well it blends in); b) how noticeable the vitiligo is and c) a reduction in the size of the white patches. The majority of respondents said they would consider 80% or more repigmentation to be a worthwhile treatment response after 9 months of treatment. Three online discussion groups involving 12 participants led to consensus that treatment success is best measured by asking patients how noticeable their vitiligo is after treatment. This was judged to be best answered using a 5-point Likert scale, on which a score of 4 or 5 represents treatment success. CONCLUSIONS: This study represents the first step in developing a patient reported measure of treatment success in vitiligo trials. Further work is now needed to assess its construct validity and responsiveness to change. BioMed Central 2014-06-14 /pmc/articles/PMC4075774/ /pubmed/24929563 http://dx.doi.org/10.1186/1471-5945-14-10 Text en Copyright © 2014 Tour et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Tour, Selina K
Thomas, Kim S
Walker, Dawn-Marie
Leighton, Paul
Yong, Adrian SW
Batchelor, Jonathan M
Survey and online discussion groups to develop a patient-rated outcome measure on acceptability of treatment response in vitiligo
title Survey and online discussion groups to develop a patient-rated outcome measure on acceptability of treatment response in vitiligo
title_full Survey and online discussion groups to develop a patient-rated outcome measure on acceptability of treatment response in vitiligo
title_fullStr Survey and online discussion groups to develop a patient-rated outcome measure on acceptability of treatment response in vitiligo
title_full_unstemmed Survey and online discussion groups to develop a patient-rated outcome measure on acceptability of treatment response in vitiligo
title_short Survey and online discussion groups to develop a patient-rated outcome measure on acceptability of treatment response in vitiligo
title_sort survey and online discussion groups to develop a patient-rated outcome measure on acceptability of treatment response in vitiligo
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075774/
https://www.ncbi.nlm.nih.gov/pubmed/24929563
http://dx.doi.org/10.1186/1471-5945-14-10
work_keys_str_mv AT tourselinak surveyandonlinediscussiongroupstodevelopapatientratedoutcomemeasureonacceptabilityoftreatmentresponseinvitiligo
AT thomaskims surveyandonlinediscussiongroupstodevelopapatientratedoutcomemeasureonacceptabilityoftreatmentresponseinvitiligo
AT walkerdawnmarie surveyandonlinediscussiongroupstodevelopapatientratedoutcomemeasureonacceptabilityoftreatmentresponseinvitiligo
AT leightonpaul surveyandonlinediscussiongroupstodevelopapatientratedoutcomemeasureonacceptabilityoftreatmentresponseinvitiligo
AT yongadriansw surveyandonlinediscussiongroupstodevelopapatientratedoutcomemeasureonacceptabilityoftreatmentresponseinvitiligo
AT batchelorjonathanm surveyandonlinediscussiongroupstodevelopapatientratedoutcomemeasureonacceptabilityoftreatmentresponseinvitiligo